Attenuating systemic inflammatory markers in simulated high-altitude exposure by heat shock protein 70-mediated hypobaric hypoxia preconditioning in rats  by Wang, Chia-Ti et al.
Journal of the Formosan Medical Association (2015) 114, 328e338Available online at www.sciencedirect.com
journal homepage: www.j fma-onl ine.comORIGINAL ARTICLEAttenuating systemic inflammatory markers
in simulated high-altitude exposure by heat
shock protein 70-mediated hypobaric
hypoxia preconditioning in ratsChia-Ti Wang a, Hung-Jung Lin a,b, Bor-Chih Cheng b,c, Mao-Tsun Lin d,
Ching-Ping Chang b,*aDepartment of Emergency Medicine, Chi Mei Medical Center, Tainan, Taiwan
bDepartment of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan
cDepartment of Surgery, Chi Mei Medical Center, Tainan, Taiwan
dDepartment of Medical Research, Chi Mei Medical Center, Tainan, Taiwan
Received 27 July 2012; received in revised form 22 October 2012; accepted 23 November 2012KEYWORDS
cytokines;
free radicals;
heat shock protein
70;
high-altitude
exposure;
hypobaric hypoxia
preconditioning;
multiple organ
dysfunction
syndromeConflicts of interest: The authors
* Corresponding author. Departmen
Yungkang Dist., Tainan City 710, Taiw
E-mail address: jessica@mail.stust
0929-6646/$ - see front matter Copyr
http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: The primary goal of this study was to test whether high-altitude expo-
sure (HAE: 0.9% O2 at 0.47 ATA for 24 hours) was capable of increasing the systemic inflamma-
tory markers as well as the toxic organ injury indicators in rats, with a secondary goal to test
whether preinduction of heat shock protein (HSP) 70 by hypobaric hypoxia preconditioning
(HHP: 18.3% O2 at 0.66 ATA for 5 h/day on 5 days consecutively for 2 weeks) attenuated the
proposed increased serum levels of both the systemic inflammatory markers and the toxic
organ injury indicators.
Methods: Rats were assigned to: (1) non-HHP (21% O2 at 1.0 ATA)þnon-HAE (21% O2 at 1.0 ATA)
group; (2) non-HHPþHAE group; (3) HHPþnon-HAE group; (4) HHPþHAE group; and (5)
HHPþHSP70 antibodies (Ab)þHAE group. For the HSP70Ab group, a neutralizing HSP70Ab was
injected intravenously at 24 hours prior to HAE. All the physiological and biochemical param-
eters were obtained at the end of HAE or the equivalent time period of non-HAE. Blood
samples were obtained for determination of both the systemic inflammatory markers (e.g.,
serum tumor necrosis factor-a, interleukin-1b, E-selectin, intercellular adhesion molecule-1,
and liver myeloperoxidase activity) and the toxic organ injury indicators (e.g., nitric oxide
metabolites, 2,3-dihydroxybenzoic acid, and lactate dehydrogenase).have no conflicts of interest relevant to this article.
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High-altitude exposure in rats 329Results: HHP, in addition to inducing overexpression of tissue HSP70, significantly attenuated
the HAE-induced hypotension, bradycardia, hypoxia, acidosis, and increased tissue levels of
both the systemic inflammatory markers and the toxic organ injury indicators. The beneficial
effects of HHP in inducing tissue overexpression of HSP70 as well as in preventing the HAE-
induced increased levels of the systemic inflammatory markers and the toxic organ injury indi-
cators could be significantly reduced by HSP70Ab preconditioning.
Conclusion: These results suggest that HHP may downgrade both the systemic inflammatory
markers and the toxic organ injury indicators in HAE by upregulating tissue HSP70.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Hypoxia encountered at high-altitude exposure (HAE) is
associated with acute mountain sickness, high-altitude
pulmonary edema (HAPE), and high-altitude cerebral
edema.1 People who travel to high altitude are commonly
confronted with problems such as mental dysfunction and
memory deficit,2 insomnia, dizziness, nausea,3 hypophagia4
and motor impairment.5 The HAE-induced acute pulmonary
edema is thought to be related to increased sympathetic
tone, exaggerated hypoxic pulmonary vasoconstriction,
decreased hypoxic ventilator drive, increased pulmonary
capillary pressure, failure of pulmonary capillaries, and
alveolar fluid leak across capillary endothelium.6 In addi-
tion, high-altitude pulmonary hypertension is associated
with a free radical-mediated reduction in pulmonary nitric
oxide bioavailability.7 In addition to the hydrostatic stress,
increased alveolarecapillary permeability caused by
inflammation may be necessary or causal. For example,
Schoene and colleagues8,9 found that neutrophils and
elevated concentrations of plasma proteins, thromboxane
metabolites, and proinflammatory cytokines in bron-
choalveolar lavage fluid were observed in patients with
well-established HAE. In animals, severe hypoxia (0e3%
oxygen) stimulates vascular endothelial cells, leukocytes
and macrophages in vitro to release proinflammatory
cytokines.1013 In rats, a simulated HAE (0.9% O2 at 0.47
ATA for 24 hours) caused pulmonary edema, inflammation,
and hemorrhage14,15 as well as brain edema, hippocampal
oxidative stress, and cognitive dysfunction.16
It has been well documented that the pathogenesis of
multiple organ dysfunction syndrome (MODS) in septic
shock is related to tissue production and release of the
systemic inflammatory markers including proinflammatory
cytokines interleukin-6 (IL-6), interleukin-1b (IL-1b), tumor
necrosis factor-a (TNF-a), and myeloperoxidase and the
toxic organ injury indicators nitric oxide metabolites (NOx
),
dihydroxybenzoic acid (DHBA), and lactate dehydrogenase
(LDH) in rats.17,18 It is not known whether HAE, like toxic
septic shock, is able to cause elevation of both the systemic
inflammatory markers and the organ injury indicators.
Hypobaric hypoxia preconditing (HHP) is known to
increase blood hemoglobin and tissue oxygen delivery19,20
and to increase the neuronal resistance to subsequent
severe hypoxia.21,22 More recently, we observed that HHP
[18.3% O2 at 0.66 ATA (atmosphere absolute) for 5 h/day on
5 days consecutively for 2 weeks] in rats, in addition to
inducing lung overexpression of HSP70, significantlyattenuated the HAE-induced pulmonary edema, inflamma-
tion, and ischemic and oxidative damage in rats.15 Again, it
is unknown whether the proposed HAE-induced increased
systemic inflammatory markers and the toxic organ injury
indicator can be affected by HSP70-mediated HHP.
Therefore, the present study was first to assess the
changes of the tissue levels of the systemic inflammatory
markers, the organ injury indicators, the cardiovascular
parameters, and the blood gas and acidebase parameters
during HAE in rats without or with HHP. Then, the secondary
aimwas to determinewhether the proposed beneficial effect
of HHP in reducing the systemic inflammatory markers and
the toxic organ injury indicators during HAE is caused by the
preinduction of HSP70 prior to the onset of HAE.
Materials and methods
Animals
Adult SpragueeDawley rats (weight 254  12 g) were ob-
tained from the Animal Resource Center of the National
Science Council of the Republic of China (Taipei, Taiwan).
The animals were housed four in a group at an ambient
temperature of 22  1C, with a 12-hour light/dark cycle.
Pellet rat chow and tap water were available ad libitum. All
protocols were approved by the Animals Ethics Committee
of the Chi Mei Medical Center (Tainan, Taiwan) in accor-
dance with the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health, as well as the
guidelines of the Animal Welfare Act (IACUC Approval No:
100052305). At the end of the experiments, control rats and
any rats that had survived HAE were killed with an overdose
of sodium pentobarbital.
Experimental groups and hypobaric hypoxia
preconditioning (HHP)
Rats were randomly assigned to one of the following five
groups: (a) the (non-HHPþnormobaric air (NBA)) group:
animals were treated with non-HHP or NBA (21% O2 at 1.0
ATA) for 2 weeks plus NBA; (b) the (non-HHPþHAE) group:
animals were treated with non-HHP or NBA for 2 weeks plus
HAE (9.7% O2 at 0.47 ATA); (c) the (HHPþNBA) group:
animals were treated with HHP [13.9% O2 at 0.66 ATA
(atmosphere absolute) for 5 h/day on 5 days consecutively
for 2 weeks] plus NBA; (d) the (HHPþHAE) group: animals
were treated with HHP plus HAE; and (e) the
330 C.-T. Wang et al.(HHPþHSP70AbþHAE) group: animals were treated with
HHP plus HSP70Ab and HAE. The (nonþHHPþHAE) group,
the (HHPþHAE) group, and the (HHPþHSP70AbþHAE) group
rats were subjected to simulated HAE at 2 weeks after the
start of non-HHP or HHP (Fig. 1).
A simulated HAE model
HHP rats or non-HHP rat were randomly exposed to
a simulated HAE (9.7% O2 at 0.47 ATA) of 6000 m (or 19,685
feet) in a hypobaric chamber (Institute of Aviation Medi-
cine, Beijing, China) for 24 hours.14,15 The temperature of
the hypobaric chamber was maintained at 25  1C and
humidity at 40e50% with an air flow rate of 4 L/h and
a barometric pressure of 355 mmHg the animals were
provided with adequate quantities of food and water during
hypoxic exposure.
Inhibition of HSP70 activity
The protective role of HSP70 in the rat brain7,23 or in the rat
lung15 has been studied previously by using anti-HSP70
antibody (Ab). A neutralizing polyclonal rabbit anti-mouse
HSP70Ab (0.2 mg/kg of body weight; SPA-812 E, Assay
Designs) dissolved in nonpyrogenic sterile saline was
injected intravenously at 24 hours before simulated HAE.
Experimental protocols
In Experiment 1, non-HHP rats (n Z 8), HHP rats (n Z 8),
and (HHPþHSP70Ab) rats (n Z 8) were killed by decapita-
tion and their livers were removed for determination of
protein expression of HSP70. (Fig. 1)
In Experiment 2, all the non-HHP rats (n Z 8), HHP rats
(nZ 8), and HHPþHSP70Ab rats (nZ 8) were subjected to
HAE for 24 hours and their effects on values of mean
arterial pressure (MAP), heart rates (HR), and blood levels
of PaCO2, SO2, HCO3
, and pH were determined in these
groups of rats under general anesthesia of an intraperito-
neal (i.p.) dose of sodium pentobarbital (60 mg/kg of bodyFigure 1 Experimental design. The HHP group received 18.3% O
weeks. These three groups of rats were subjected to HAE (9.8%
HHP Z hypobaric hypoxia preconditioning; HSP70Ab Z heat shockweight). Both (non-HHPþNBA) group and (HHPþNBA) group
rats were used as controls.
In Experiment 3, 24 hours after HAE, all the non-HHP rats
(n Z 8), HHP rats (n Z 8), and HHPþHSP Ab rats (n Z 8)
were killed by decapitation and their bloods were obtained
for determination of serum levels of glutamate, lactate-to-
pyruvate ratio, glycerol, NOx, 2,3-DHBA, IL-1b, TNF-a, IL-
10, E-selectin, soluble intercellular adhesion molecule-1
(ICAM-1) and LDH. In addition, their liver tissues were ob-
tained for determination of myeloperoxidase (MPO)
activity. Both the (non-HHPþNBA) group rats and the
(HHPþNBA) rats were used as controls.
Physiologic variable monitoring
At the end of HAE for the HAE group or the equivalent time
period for the NBA group, the animals were anesthetized
and their bilateral femoral arteries were cannulated using
polyethylene tubes. One tube was used for continuous
monitoring of MAP and heart rate (HR) via a pressure
transducer, whereas the other was used for collecting blood
samples to determine the animal’s arterial pH, PaCO2, SO2,
and HCO3
, levels. Both the MAP and HR were recorded
using a polygraph. Core temperature was monitored by
a thermocouple inserted into the rectum. The core
temperature was maintained at a constant level of w37C
with a hot water circulating heating pad. After stabiliza-
tion, all physiologic variables were obtained for data
presentation and then the blood samples were obtained for
biochemical determination.
Protein preparation
Peripheral liver tissues were frozen in liquid nitrogen and
then stored at 80C until analyzed. The tissue was
homogenized in ice-cold isolation solution (250 mmol/L
sucrose, 10 mmol/L triethanolamine, 1 mg/mL leupeptin
and 0.1 mg/mL phenylmethyl sulfonyl fluoride (PMSF)).
Homogenates were centrifuged at 12000 rpm for 10 minutes
at 4C to separate incompletely homogenized tissue. The
supernatants were obtained and the protein concentrations2 at 0.66 ATA for 5 hours daily for 5 days consecutively for 2
O2 at 0.47 ATA) for 24 hours. HAE Z high-altitude exposure;
protein 70 antibody; NBA Z normobaric air.
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Taiwan). For deglycosylation of proteins, an N-glycosidase F
Deglycosylation kit (Roche) was used.
Western blot analysis
Total proteins (50 mg/sample) were diluted in 5 loading
buffer [0.25 mol/L Tris/HCl (pH 6.8), 10% sodium dodecyl
sulfate (SDS), 0.5% bromophenol blue, 50% glycerol and
0.5 mol/L dithiothreitol and then boiled for 5 minutes. SDS/
polyacrylamide gel electrophoresis (PAGE) was carried out
on 12% gradient gels. The proteins were electrophoretically
transferred onto polyvinylidene fluoride (PVDF) membranes
treated previously with methanol and blocked for 1 hour at
room temperature (24C) in Tris-buffered saline containing
0.1% Tween-20 (TBS-T) containing 5% nonfat dried milk.
Membranes were incubated overnight at 4C with an anti-
HSP70 antibody (1:40000 dilution; Santa Cruz Biotech-
nology, CA, USA) in TBS-T containing 5% nonfat dried mild.
After washing in TBS-T, the membranes were incubated
with horseradish peroxidase-labeled anti-rabbit antibody
(Santa Cruz, 1:3000) for 2e3 hours at room temperature.
Blots were developed with enhanced chemiluminescence
agents (ECL plus; Sunbio) before exposure to X-ray film. To
confirm equivalent loading of samples, the same
membranes were incubated with an anti-b-actin antibody
(1:1000 dilution; Santa Cruz Biotechnology) and was visu-
alized via enhanced chemiluminescence as described
above. For quantification, Western blots were scanned
using a Minolta scanner and Adobe Photoshop software. The
labeling density was quantified using Lab-Works software
(UVP). The relative density of the HSP70 band was
normalized to the density of the b-actin band to represent
the amount of HSP70 protein. The ratio of non-HHP group
was regarded as 100%, and the results for HHP and
HHPþHSP70Ab group are expressed as a percentage of the
value from the non-HHP group.
Determination of proinflammatory cytokines,
glutamate, glycerol, lactate-to-pyruvate ratio, 2,3-
dihydroxybenzoic acid (2,3-DHBA), nitric oxide
metabolites (NOx
L), LDH and ICAM-1
At the end of the experiments, the animals were killed and
blood samples were collected. After centrifugation, the
serum was frozen at 80C for biochemical determination.
The concentration of TNF-a, IL-1b, IL-10, and ICAM-1 were
determined using double-antibody sandwich ELISA (R&D
systems, Minneapolis, MN, USA) according to the manufac-
turer’s instruction. Optical densities were read on a plate
reader set at 450 nm for TNF-a, IL-1b, IL-10, and ICAM-1.
The concentration of cytokines in the samples were
calculated from the standard curve multiplied by the
dilution factor and were expressed as pg/mL. For deter-
mination of the glutamate and glycerol levels, and the
lactate-to-pyruvate ratio, aliquots of samples were injec-
ted into a CMA600 microdialysis analyzer (Carnegie Medi-
cine, Stockholm, Sweden).24
Nitric oxide is an unstable molecule that is easily
degraded into nitrite (NO2
) and nitrate (NO3
) ions.25 NO2

and NO3
 levels were measured using the HPLC-NO detectorsystem (ENO-10; Eicom, Kyoto, Japan), as previously re-
ported.26 In brief, NO2
 and NO3
were separated on a reverse
phase column (NO-PAK, 4.6  50 mm; Eicom, Kyoto, Japan)
and NO3
was reduced to NO2
 by passage through a reduction
column (NO-RED; Eicom, Kyoto, Japan). NO2
 was deter-
mined as the azo dye compound by the Griess reaction using
a spectrophotometer. These oxidative NOproductswere also
evaluated as NOx
 (NO2
 plus NO3
).
The concentrations of hydroxyl radicals were measured
by a modified procedure based on the hydroxylation of
sodium salicylates by hydroxyl radicals, leading to the
production of 2,3-DHBA and 2,5-DHBA.27,28 A Ringer’s
solution containing 0.5 mM sodium salicylates was perfused
through the microdialysis probe at a constant flow rate
(1.2 mL/min). An Alltrina reverse-phase C18 column (BAS,
150  1 mm ID, particle size 5 mm) was used to separate the
DHBAs, and the mobile phase consisted of a mixture of 0.1M
chloroacetic acid, 26.87 nM disodium EDTA, 688.16 nM
sodium octyl sulfate, and 10% acetonitrile (pH3.0). The
retention time of 2,3-DHBA and 2,5-DHBA were 8.1 and 6.0
minutes, respectively. In addition, LDH was measured to
evaluate the extent of organ injury by Fuji DRI-CHEM 3030
(Fuji Photo film Co., Tokyo, Japan).
Measurement of E-selectin
Rat peripheral polymorphonuclear (PMN) cells were iso-
lated from the whole blood of rats and treated with heparin
(100 units/mL). Erythrocytes were allowed to sediment for
30 minutes after the addition of 1 mL of 6% dextran
(weight/volume in PBS) to 10 mL blood. After sedimenta-
tion, the plasma containing leukocytes was centrifuged
twice at 300g for 5 minutes each. The precipitates were
mixed with 70% osmolality-adjusted Percoll and centrifuged
at 30,000g for 30 minutes at 26C. The PMN-riched layer
was fractionated. Each fraction was washed twice with
Hank’s balanced salt solution, and the cell number was
counted. The purity of the PMNs was determined to exceed
95% by Giemsa staining cells (1  106 cells/tube) were
incubated with a rabbit polyclonal antibody to CD62E
(ab1898; Abcam PIC332, Cambridge, UK) or control. After
washing, the cells were stained with a secondary-antibody
(goat polyclonal to rabbit immunoglobulin G (IgG)-HCl
[FITC]. [ab6717]; Abcam PIC). Cells were incubated for 1
hour at 4C and washed. The cells were mixed with oligo-
saccharide dyes and incubated for 20 minutes, and then co-
incubated with KM93 for 60 minutes. The fluorescence
intensity of cells was analyzed with a FACStar (Becton
Dickinson, Franklin Lakes, NJ, USA).
Determination of myeloperoxidase activity
A spectrophotometric method was used to determine MPO
activity in the liver.29 A 100-mL aliquot of serum was mixed
with 900 mL of 50 mmol/L phosphate buffer (pH 6.0) con-
taining 0.167 mg/mL of O-dianisidine dihydrochloride and
0.0005% hydrogen peroxide. One unit of peroxidase activity
(i.e., the amount of enzyme decomposing 1 mmol of
hydrogen peroxide) was calculated from the oxidation of O-
dianisidine using an absorption coefficient of 11.3/mM/cm
at 460 nM.
332 C.-T. Wang et al.Statistical analysis
All quantitative data were evaluated for Gaussian (normal)
distribution. Values are expressed as means  standard
error (SE) and were analyzed with one-way analysis of
variance (ANOVA), followed by the NewmanneKeuls post
hoc test if p < 0.05. For all statistical analyses, SPSS soft-
ware version 10.0 (SPSS Inc., Chicago, IL, USA) was used.
Results
HHP increased HSP70 protein in liver tissues
Western blot analysis revealed that expression of HSP70
protein in liver tissues from the HHP group was significantly
higher than those from the non-HHP group (p < 0.01;
Fig. 2). However, the expression of HSP70 protein in liver
tissues from the HHPþHSP70Ab group was significantly
lower than those from the HHP group (p < 0.01; Fig. 2).
HHP reduced HAE-induced decrease in MAP, HR,
SO2, PaCO2, HCO3
L and pH values after HAE
The values of MAP, HR, and blood levels of PaCO2, SO2,
HCO3
L and pH in the non-HHP rats were significantly lowerFigure 2 (A) Immunoblot of HSP70. (B) Western blot analysis
of HSP70 in the liver of non-HHP rats (nZ 8), HHP rats (nZ 8),
and HHPþHSP70Ab rats (n Z 8). Fold-change values represent
a mean of eight samples (n Z 8) divided by the mean of the
eight controls (n Z 8). Data are presented as means  SD.
* p < 0.01 for the HHP group versus the non-HHP group.
þ p < 0.01 for the HHPþHSP70Ab group versus the HHP group.
HHP Z hypobaric hypoxia preconditioning; HSP70 Z heat
shock protein 70; HSP70Ab Z heat shock protein 70 antibody.24 hours after HAE than for the non-HAE controls (non-
HHPþNBA group or HHPþNBA group; Fig. 3). However, HHP
significantly reduced the HAE-induced decrease of MAP, HR,
and blood levels of PaCO2, HCO3
L, SO2, and pH. Addition-
ally, HSP70Ab preconditioning significantly reduced the
beneficial effects of HHP in HAE (Fig. 3).
HHP reduced HAE-induced the increase in toxic
oxidizing radicals and toxic organ damage indicator
The blood levels of toxic oxidizing agents like NOx
L and 2,3-
DHBA and the toxic organ damage indicator like LDH in the
non-HHP rats were significantly higher 24 hours after HAE
than for the non-HAE controls (non-HHPþNBA group or
HHPþNBA group) (Fig. 4). The HAE-induced increased blood
levels of the toxic oxidizing radicals and the toxic organ
damage indicator were all significantly reduced by HHP
(Fig. 4). Again, the beneficial effects of HHP in HAE were
significantly attenuated by HSP70Abs preconditioning
(Fig. 4).
HHP attenuated HAE-induced increased serum
levels of systemic inflammatory response
molecules
The blood levels of systemic inflammatory response mole-
cules including IL-1b, TNF-a, E-selectin, ICAM-1, and liver
levels of MPO activity in the non-HHPþHAE group rats were
all significantly higher 24 hours after HAE than for the non-
HAE controls (non-HHPþNBA group or HHPþNBA group)
(Fig. 5). HHP, in addition to increasing blood levels of an
antiinflammatory cytokine like IL-10, significantly reduced
HAE-induced increased blood levels of IL-1b, TNF-a, E-
selectin and ICAM-1 and increased liver levels of MPO
activity 24 hours after HAE. Again, the beneficial effects of
HHP in inhibiting activated inflammation that occurred 24
hours after HAE were all significantly attenuated by
HSP70Ab preconditioning (Fig. 5).
Discussion
The reduction in barometric pressure and the consequent
fall in the PaO2 at higher altitudes lead to hypobaric
hypoxia. If the hypoxia is severe or sustained, as shown in
the present results, a drop of the oxygen saturation in
multiple organs is inevitable leading to MODS. Indeed, as
demonstrated in the current study, 24 hours after the start
of HAE, the non-HHP animals displayed hypoxia, hypoten-
sion, bradycardia, acidosis, and tissue upregulation of both
the systemic inflammatory markers including TNF-a,
soluble intercellular adhesion molecule-1, E-selectin, IL-1b,
IL-6, and myeloperoxidase, and the toxic organ injury
indicators including NOx, DHBA, and LDH. In addition, our
previous finding showed that directly after being taken out
to the ambient from exposure to simulated HAE of 6000 m
in a hypobaric chamber for 24 hours, the non-HHP animals
had higher scores of acute lung injury, acute pleurisy,
increased proinflammatory cytokines, and increased
cellular ischemia and oxidative damage markers in the
bronchoalveolar fluid.15 Furthermore, HAE caused brain
Figure 3 Values of mean arterial pressure (MAP), heart rate (HR), and the percentage of oxygen saturation (SO2%), PaCO2, HCO3
,
and pH in the blood for the (non-HHPþNBA) group, (HHPþNBA) group, (non-HHPþHAE) group, (HHPþHAE) group, and
(HHPþHSP70AbþHAE) group obtained at the end of HAE or the equivalent time period for the NBA group. Data are presented as
means  SD of n Z 8 each group. * p < 0.05 for the (non-HHPþHAE) group versus the (non-HHPþNBA) group. þ p < 0.05 for the
(HHPþHAE) group versus (non-HHPþHAE) group; xp < 0.05 for (HHPþHSP70AbþHAE) group. HAE Z high-altitude exposure;
HHP Z hypobaric hypoxia preconditioning; HSP70Ab Z heat shock protein 70 antibody; NBA Z normobaric air.
High-altitude exposure in rats 333edema, hippocampal oxidative damage and cognitive
dysfunction in rats.16 Putting these observations together,
it can be inferred that MODS can be induced by HAE in rats.
This statement is at least in part consistent with the current
concept that the acute adult syndromes of high altitude areacute mountain sickness, HAPE and high-altitude cerebral
oedema.30 The present data also support the idea that
human responses to the hypobaric hypoxia of high altitude
may be used as a means of exploring elements of the
pathophysiology of critical illness.30
Figure 4 Values of serum LDH, NOx
, and 2,3-DHBA for the
(non-HHPþNBA) group, (HHPþNBA) group, (non-HHPþHAE)
group, (HHPþHAE) group, and (HHPþHSP70AbþHAE) group ob-
tained at the end of HAE or the equivalent time period for the
NBA group. Data are presented as means  SD of nZ 8 for each
group. * p < 0.05 for the (non-HHPþHAE) group versus the (non-
HHPþNBA) group. þp< 0.05 for the (HHPþHAE) group versus the
(non-HHPþHAE) group. x p < 0.05 for the (HHPþHSP70AbþHAE)
group versus the (HHPþHAE) group. DHBAZ dihydroxybenzoic
acid; HAEZ high-altitude exposure; HHPZ hypobaric hypoxia
preconditioning; HSP70Ab Z heat shock protein 70 antibody;
LDH Z lactate dehydrogenase; NBA Z normobaric air;
NOx
Z nitric oxide metabolites.
334 C.-T. Wang et al.It is well documented that HSP70 induced by physiologic
and pathological stress protects against subsequent damage
via increasing the tolerance of affected tissues.31,32 Chronic
hypoxia improved acute myocardial stress,33 severesepsis,34 ischemic penumbra,35,36 and heatstroke37,38 by
upregulating HSP70. Indeed, as shown in the present
results, the (HHPþNBA) group rats shared with the (non-
HHPþNBA) group rats the same levels of the physiological
parameters, the systemic inflammatory markers and the
toxic organ injury indicators. However, compared with
those of the (non-HHPþNBA) or the (HHPþNBA) group rats,
the (HHPþHAE) group rats had significantly higher levels of
both the systemic inflammatory markers and the toxic
organ injury indicators. HHP, in addition to inducing HSP70
in multiple organs significantly attenuated the HAE-induced
increased tissue levels of both the systemic inflammatory
markers and the toxic organ injury indicators. Our results
showed that preinduction of HSP70 protein with a sublethal
dose of HAE (e.g., HHP: 18.3% O2 at 0.66 ATA) were able to
protect against a subsequent lethal damage exerted by
a lethal dose of HAE (9.7% O2 at 0.47 ATA).
The beneficial effects of HHP in preventing the occur-
rence of the increased systemic inflammatory markers and
the toxic organ injury indicators could be significantly
attenuated by HSP70Ab preconditioning. Thus, it appears
that HHP may attenuate HAE-induced systemic inflamma-
tion and MODS by upregulating HSP70 in multiple organs.
Again, our current results are supported by the findings of
Zhang et al.39 Their results suggested that administration of
geranylgeranylacetone prevented acute hypoxic damage to
the brain and that the underlying mechanism involved
induction of HSP70.39 Recently, it has been shown that
intravenously administered HSP70 neutralizing Abs bind to
the intracellular pool of HSP70 antigen in the neurons and
significantly attenuate the expression of HSP70 in brain
tissue.8 In the present study, we followed the same regimen
as those of Liebelt et al.8 and observed that HHP induced
a 100% higher expression of HSP70. Inhibition of this HSP70
expression with Ab, which might affect the intracellular
pool of HSP70 protein, blocked HAE-induced increased
levels of the systemic inflammatory markers as well as the
toxic organ injury indicators. In future studies, it would be
worthwhile assessing what is the line between HHP and
HAE. That is, to bring the protective effect of HHP on HAE,
to what extent is this strategy effective rather than also
detrimental?
Various serum molecules like TNF-a, IL-1b, ICAM-1 and E-
selectin were shown to be related to the pathophysiology of
systemic inflammatory response syndrome.40,41 As shown in
the present study, the full spectrum of the systemic
inflammatory response syndrome molecules could be
induced by HAE. HHP, in addition to inducing both HSP70
and IL-10, significantly ameliorated the HAE-induced
increased serum systemic inflammatory syndrome mole-
cules. It should be stressed that the serum levels of IL-10
are believed to be an antiinflammatory cytokine.42 It is
possible that HHP-induced overexpression of HSP70 may
downregulate the production or release of these systemic
inflammatory markers but upregulate the production or
release of serum IL-10. Inhibition of HSP70 activity by
HSP70Ab preconditioning abolished the beneficial effects of
HHP in HAE. Although the aforementioned observations
tended to support the causal role played by activated
inflammation in the pathogenesis of HAE-induced MODS,
prospective human studies measuring proinflammatory
cytokines in plasma and other related parameters found no
Figure 5 Values of serum IL-1b, TNF-a, IL-10, E-selectin, ICAM-1, and liver MPO activity for the (non-HHPþNBA) group,
(HHPþNBA) group, (non-HHPþHAE) group, (HHPþHAE) group, and (HHPþHSP70AbþHAE) group obtained at the end of HAE or the
equivalent time period for the NBA group. Data are presented as mean  SD of n Z 8 for each group. * p < 0.05 for the (non-
HHPþHAE) group versus the (non-HHPþNBA) group. þ p < 0.05 for the (HHPþHAE) group versus the (non-HHPþHAE) group.
x p < 0.05 for the (HHPþHSP70AbþHAE) group versus the (HHPþHAE) group. HAE Z high-altitude exposure; HHP Z hypobaric
hypoxia preconditioning; HSP70Ab Z heat shock protein 70 antibody; ICAM-1 Z intercellular adhesion molecule-1;
IL Z interleukin; MPO Z myeloperoxidase; NBA Z normobaric air; TNF Z tumor necrosis factor.
High-altitude exposure in rats 335evidence for inflammation before or with the onset of
HAPE.43,44 Swenson et al.5 further demonstrated that early
HAPE was characterized by pulmonary hypertension that
led to pulmonary edema, with normal levels of leukocytes,cytokines and eicasanoids. Besides inflammation, other
parameters like hypoxia, hypotension, bradycardia,
acidosis, and overproduction of toxic-oxidizing radicals may
be related to the occurrence of HAPE.
336 C.-T. Wang et al.It was reported that hypoxia caused excitotoxicity of
cells by activating nitric oxide synthase and generating
NOx.
43 Generation of NOx and 2,3-DHBA after hypoxia could
cause protein oxidation,44 lipid oxidation,45 or cell death.
Maiti and colleagues46 showed that an increase in 2,3-DHBA
and NOx levels was noted in the rat brain which was
exposed to simulated high altitude equivalent to 6100 m in
animal decompression chamber for 3e7 days. Our present
results also showed that the non-HHP animals had increased
2,3-DHBA and NOx levels in serum after simulated HAE of
6000 m for 24 hours. 2,3-DHBA and NOx are two well-known
markers of cellular oxidative damage.47,48 The organ injury
indicator like LDH17,18 in serum was also increased in our
animals 24 hours after HAE. Additionally, the beneficial
effects of HHP in reducing cellular oxidative damage to
multiple organs could be significantly attenuated by
HSP70Ab preconditioning.
The results obtained here show that HHP in addition to
inducing overproduction of HSP70 and IL-10, protects
against the MODS that occurred during simulated HAE of
6000 m for 24 hours in rats. The beneficial effects of HHP
may be attributed to the inhibition of: (1) production or
release of systemic inflammatory response markers
including serum TNF-a, IL-1b, ICAM-1, and E-selectin and
liver myeloperoxidase activity; (2) production or release of
the toxic organ injury indicators including NOx
, 2,3-DHBA
and LDH; and (3) hypoxia, hypotension, bradycardia, and
acidosis, and thus, leading to an improvement in rats with
HAE-associated MODS. The beneficial effects of HHP in
preventing the occurrence of HAE-associated MODS could
be significantly reduced by HSP70Ab preconditioning. It is
inferred that HHP may attenuate the occurrence of the
MODS caused by HAE by upregulating HSP70 in rats.
Evidence has accumulated to indicate that hypoxic
preconditioning protects against ischemic brain injury in
animals.4952 Our previous15 and present results also show
that hypoxic preconditioning may be beneficial for pre-
venting overproduction of both the systemic inflammatory
markers and the toxic organ injury indicators in HAE. In
fact, the most popular preventive approach for HAPE is
gradual ascending,53 which is actually a type of hypoxia
preconditioning. However, it has also been found that
hyperbaric oxygen preconditioning (HBO2P) elicits similar
preconditioning efficacy in reducing ischemic brain
damage.54 Although HHP possesses significant protection in
preventing tissue damage, it has not been used clinically
because of safety concerns. In contrast, HBO2P is more
attractive and easily accepted ethically because it has been
used safety for various disorders.5557 Recently, we have
demonstrated reducing pulmonary injury by HBO2P
14 or
HHP15 during simulated HAE in rats. Preinduction of HSP70
in various organs including brain16 and lung,15 respectively,
by HBO2P and HHP is found to be beneficial in improving the
outcome of HAE in rats. Our present results further show
that attenuating systemic inflammatory markers in simu-
lated HAE by HSP70-mediated HHP in rats. Putting these
observations together, it appears that HHP or HBO2P
attenuates HAE-induced tissue injury by preinduction of
HSP70 in multiple organs. HBO2P increased tissue oxygen
levels by giving 100% oxygen at higher pressure. After
HBO2P therapy, the body experiences relative hypoxia
because the oxygen level was returned to a normal level of21%. Therefore, repeating HBO2P therapy may produce
a cycle of hyperoxia and then hypoxia, and head to
hypoxia-inducing factor-1a (HIF-1a) accumulation. Several
studies reported that HBO2 therapy induced hypoxic toler-
ance by upregulating HIF-1a and its downstream
genes.5860 Thus, it appears that both HBO2P and HHP
improve the outcome of HAE by preinduction of both HSP70
and HIF-1a in various organs at least.
This experiment has several limitations. First, our study
used very low numbers of animals. Second, the rat model of
HAE resembles the physiologic response of a primate only to
a certain point. It cannot predict exactly the human
response by extrapolation of data from our rat model. Our
approach is promising and deserves further preclinical and
clinical research to explore elements of the pathophysi-
ology of critical illness.
It should be mentioned that we have previously
demonstrated that a sublethal dose of heat shock (42 C for
only 15 minutes) induced HSP70 protein overexpression in
the tissue that was detected 4 hours after treatment.61 This
heat treatment did not cause heatstroke syndromes (e.g.,
hypotension and reduced survival). In contrast, a lethal
dose of heat shock (43 C for 60 minutes) did not induce
HSP70 overexpression but caused heatstroke syndromes.
Heat shock preconditioning (42 C for 15 minutes) induced
HSP70 which was correlated well with anatomical histo-
chemical, and hemodynamic protection in heatstroke. It is
likely that HHP, but not HAE, induced overexpression of
tissue HSP70 which was correlated with protection in high
mountain sickness.
In summary, the current study demonstrates that
preinduction of HSP70 in various organs with a sublethal
dose of HAE (e.g., HHP: 18.3% O2 at 0.66 ATA for 5 h/day on
5 days consecutively for 2 weeks) protects against a subse-
quent lethal damage (e.g., increased levels of both the
systemic inflammatory markers and the toxic organ injury
indicators) exerted by a lethal dose of HAE (9.7% O2 at 0.47
ATA for 24 hours).
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